[go: up one dir, main page]

IL108926A0 - Human t cell monoclone, process for its production and its use for the treatment and diagnosis of infectious diseases, autoimmune diseases, t-cell mediated allergies and cancer - Google Patents

Human t cell monoclone, process for its production and its use for the treatment and diagnosis of infectious diseases, autoimmune diseases, t-cell mediated allergies and cancer

Info

Publication number
IL108926A0
IL108926A0 IL10892694A IL10892694A IL108926A0 IL 108926 A0 IL108926 A0 IL 108926A0 IL 10892694 A IL10892694 A IL 10892694A IL 10892694 A IL10892694 A IL 10892694A IL 108926 A0 IL108926 A0 IL 108926A0
Authority
IL
Israel
Prior art keywords
cell
diagnosis
cancer
human
treatment
Prior art date
Application number
IL10892694A
Original Assignee
L Willems Instituut Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L Willems Instituut Dr filed Critical L Willems Instituut Dr
Publication of IL108926A0 publication Critical patent/IL108926A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0007—Nervous system antigens; Prions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/22—Immunosuppressive or immunotolerising
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/416—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/48—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL10892694A 1993-05-14 1994-03-10 Human t cell monoclone, process for its production and its use for the treatment and diagnosis of infectious diseases, autoimmune diseases, t-cell mediated allergies and cancer IL108926A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93870081 1993-05-14

Publications (1)

Publication Number Publication Date
IL108926A0 true IL108926A0 (en) 1994-06-24

Family

ID=8215343

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10892694A IL108926A0 (en) 1993-05-14 1994-03-10 Human t cell monoclone, process for its production and its use for the treatment and diagnosis of infectious diseases, autoimmune diseases, t-cell mediated allergies and cancer

Country Status (6)

Country Link
EP (1) EP0698087A1 (en)
JP (1) JPH09500261A (en)
AU (1) AU6376194A (en)
CA (1) CA2162853A1 (en)
IL (1) IL108926A0 (en)
WO (1) WO1994026876A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1218506A (en) * 1996-03-13 1999-06-02 盐野义制药株式会社 Human T cell clone specific for rheumatoid arthrilis
US7658926B2 (en) 2001-09-14 2010-02-09 Opexa Pharmaceuticals, Inc. Autologous T-cell vaccines materials and methods
AU2003258090B2 (en) 2002-08-08 2010-07-22 Baylor College Of Medicine Isolation and identification of T cells
JPWO2011096482A1 (en) * 2010-02-03 2013-06-13 国立大学法人 東京大学 Immune function reconstruction using pluripotent stem cells
US9206394B2 (en) 2010-02-03 2015-12-08 The University Of Tokyo Method for reconstructing immune function using pluripotent stem cells
US9107878B2 (en) * 2010-04-06 2015-08-18 Exocyte Therapeutics Pte, Ltd Methods of treating cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8405555D0 (en) * 1984-03-02 1984-04-04 Rees A D M Macrophage activating factors
DE3687014T2 (en) * 1985-05-01 1993-04-01 Asahi Chemical Ind TO DETECT TUMORS CAPABLE OF A CLONED T-CELL AND A T-CELL ANTIGEN RECEPTOR.
JPH0297378A (en) * 1988-10-03 1990-04-09 Asahi Chem Ind Co Ltd Cloned human killer t cell strain
EP0463101B2 (en) * 1989-03-21 2003-03-19 The Immune Response Corporation Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
AU674494B2 (en) * 1991-05-31 1997-01-02 Xoma Corporation T cell receptor peptides as therapeutics for immune-related disease

Also Published As

Publication number Publication date
WO1994026876A1 (en) 1994-11-24
JPH09500261A (en) 1997-01-14
AU6376194A (en) 1994-12-12
EP0698087A1 (en) 1996-02-28
CA2162853A1 (en) 1994-11-24

Similar Documents

Publication Publication Date Title
AU2639695A (en) Novel uses of triplex forming oligonucleotides for the treatment of human diseases
AU7678096A (en) Therapeutic medical garments for scars and process
AU1049788A (en) Methods and peptides for the treatment of non-ige-mediated diseases
IL110464A0 (en) Novel proteins for the diagnosis, imaging, and therapy of human cancer
LTIP863A (en) Aminobenzodiazepines, process for preparing thereof and application for the treatment and prevention of viral diseases
IL94251A0 (en) Hydrolyzable silicone polymers and process for synthesizing the same
ZA90245B (en) Treatment of diseases associated with hiv infections
EP0506893A4 (en) Diagnosis and treatment of diseases
AU633646B2 (en) Medical treatment apparatus using ozone gas
AU2792789A (en) Method and means for selection of anti-idiotype antibodies and their use for the diagnosis, monitoring, treatment and/or prevention of cancer, autoimmune or infectious disease
HU9802132D0 (en) Biphenyl-sulfonyl-cyanamides, process for producing them and their medical use
IL129144A0 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin diseases
IL108926A0 (en) Human t cell monoclone, process for its production and its use for the treatment and diagnosis of infectious diseases, autoimmune diseases, t-cell mediated allergies and cancer
HUP9802834A3 (en) Preparations for the treatment of t cell mediated autoimmune diseases
HU9203496D0 (en) Aza-benzimidazoles applicqbles for treatment of asthma, arthritis and similqr diseases
AU7316196A (en) Diagnosis of susceptibility to cancer and treatment thereof
AU7926487A (en) Apparatus for effect-field treatment matched with the human body's frequency spectrum and their production method
AU6491890A (en) Use of arylalkylamides in the treatment of neurodegenerative diseases
HU908272D0 (en) Process for the production of medical preparations for external treatment
AU7695891A (en) Treatment of autoimmune diseases
AU2617792A (en) Medical treatment apparatus using ozone gas
AU4757293A (en) Procedure for the treatment and shaping of hair
ZA936136B (en) Treatment of skin diseases
HU900381D0 (en) Process for producing medical preparatives utilizable for treating cancerous diseases
EP0427850A4 (en) Anti-ergotypic t cells for the treatment or prevention of autoimmune diseases and methods of use thereof